Insider · CIK 0001656082
Julia A Haller
Files at BMY (BRISTOL MYERS SQUIBB CO), OTLK (Outlook Therapeutics, Inc.). First filing -, latest -.
In brief
Julia A Haller files SEC Form 4 as director at BMY (BRISTOL MYERS SQUIBB CO), and also at OTLK (Outlook Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Julia A Haller has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | BMY BRISTOL MYERS SQUIBB CO | MOption exercise Common Stock, $0.10 par value | +20,460 | $53.76 | $1.1M | 34,079 | Jun 16, 2026 |
| Jun 15, 2026 | BMY BRISTOL MYERS SQUIBB CO | MOption exercise Option (right to buy)derivative | -20,460 | $0.00 | $0 | 0 | Jun 16, 2026 |
| Feb 1, 2026 | BMY BRISTOL MYERS SQUIBB CO | AGrant or award Deferred Share Unitsderivative | +3,996 | $55.05 | $220k | 37,903 | Feb 3, 2026 |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +286,734 | $0.00 | $0 | 286,734 | Oct 3, 2025 |
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +58,648 | $0.00 | $0 | 58,648 | Oct 3, 2025 |
| Feb 1, 2025 | BMY BRISTOL MYERS SQUIBB CO | AGrant or award Deferred Share Unitsderivative | +3,562 | $58.95 | $210k | 32,223 | Feb 4, 2025 |
| Mar 7, 2024 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +94,441 | $0.00 | $0 | 94,441 | Mar 8, 2024 |
| Feb 1, 2024 | BMY BRISTOL MYERS SQUIBB CO | AGrant or award Deferred Share Unitsderivative | +4,315 | $48.67 | $210k | 27,341 | Feb 5, 2024 |
| Dec 31, 2023 | BMY BRISTOL MYERS SQUIBB CO | AGrant or award Deferred Share Unitsderivative | +706 | $51.31 | $36k | 22,746 | Jan 3, 2024 |
Questions about Julia A Haller
Answered from the filings on this page, as of the latest one.
Is Julia A Haller buying or selling?
Julia A Haller has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Julia A Haller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julia A Haller has 0.
Where does Julia A Haller file Form 4?
Julia A Haller has filed Form 4 at BMY (BRISTOL MYERS SQUIBB CO); OTLK (Outlook Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.